Akira Fukao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Akira Fukao has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Ichiro Tsuji
Division of Epidemiology, Department of Health Informatics and Public Health, Tohoku University School of Public Health, Graduate School of Medicine
2 shared publications Akira Yajima
Department of Obstetrics and Gynecology
1 shared publication- Ali Obaid Al-Hamzawi
Al-Qadisia University College of Medicine, Diwania Teaching Hospital, Diwania, Iraq
1 shared publication - Andrzej Kiejna
Psychology Research Unit for Public Health, University of Lower Silesia, Wrocław, Poland
1 shared publication - Atsushi Tanaka
Graduate School of Science and Engineering, Yamagata University
1 shared publication - Atsushi Tsuya
Institute for Promotion of Medical Science Research, Yamagata University, Faculty of Medicine, Yamagata, Japan
1 shared publication
Latest Publications
- 1 March 2017
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 26 (2) , 125-130
The association between coffee consumption and bladder cancer incidence in a pooled analysis of the Miyagi Cohort Study and Ohsaki Cohort Study
Recent epidemiological studies of the association between coffee consumption and the risk of bladder cancer have yielded conflicting results. The aim of the present study was to examine the association between coffee consumption and the incidence of bladder cancer on the basis of pooled data from two cohort studies carried out in Miyagi Prefecture, northeastern Japan. We delivered self-administered questionnaires inquiring about the frequency of coffee consumption and other lifestyle factors in 1990 for the Miyagi Cohort Study and in 1994 for the Ohsaki Cohort Study. We followed 73 346 individuals from both cohorts and identified 274 cases of bladder cancer during 17.6 years for the Miyagi Cohort Study and 13.3 years for the Ohsaki Cohort Study. The multivariate-adjusted hazard ratios (95% confidence intervals) of bladder cancer incidence for the individuals who drank coffee occasionally, 1–2 cups/day, and 3 or more cups/day compared with never drinkers were 1.22 (0.90–1.66), 0.88 (0.61–1.26), and 0.56 (0.32–0.99), respectively (P trend=0.04). The inverse association remained even after stratification for smoking status. These data indicate that there is a significant inverse association between coffee consumption and the risk of bladder cancer.
- 1 March 2017
- Published by Wolters Kluwer Health in European Journal Of Cancer Prevention
- Vol. 26 (2) , 125-130
The association between coffee consumption and bladder cancer incidence in a pooled analysis of the Miyagi Cohort Study and Ohsaki Cohort Study
Recent epidemiological studies of the association between coffee consumption and the risk of bladder cancer have yielded conflicting results. The aim of the present study was to examine the association between coffee consumption and the incidence of bladder cancer on the basis of pooled data from two cohort studies carried out in Miyagi Prefecture, northeastern Japan. We delivered self-administered questionnaires inquiring about the frequency of coffee consumption and other lifestyle factors in 1990 for the Miyagi Cohort Study and in 1994 for the Ohsaki Cohort Study. We followed 73 346 individuals from both cohorts and identified 274 cases of bladder cancer during 17.6 years for the Miyagi Cohort Study and 13.3 years for the Ohsaki Cohort Study. The multivariate-adjusted hazard ratios (95% confidence intervals) of bladder cancer incidence for the individuals who drank coffee occasionally, 1–2 cups/day, and 3 or more cups/day compared with never drinkers were 1.22 (0.90–1.66), 0.88 (0.61–1.26), and 0.56 (0.32–0.99), respectively (P trend=0.04). The inverse association remained even after stratification for smoking status. These data indicate that there is a significant inverse association between coffee consumption and the risk of bladder cancer.
- Open Access
- 12 May 2016
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 2 (1) , e19
Medical Institutions and Twitter: A Novel Tool for Public Communication in Japan
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.
- 12 May 2016
- Published by JMIR Publications Inc. in JMIR Public Health and Surveillance
- Vol. 2 (1) , e19
Open AccessMedical Institutions and Twitter: A Novel Tool for Public Communication in Japan
A multidisciplinary journal that focuses on public health and technology, public health informatics, mass media campaigns, surveillance, and innovation in public health practice and research. Also dedicated to rapid open data sharing during epidemics.
- Open Access
- 28 March 2014
- Published by Springer Nature in Diabetologia
- Vol. 57 (6) , 1269-1270
Erratum to: Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression
- 28 March 2014
- Published by Springer Nature in Diabetologia
- Vol. 57 (6) , 1269-1270
Open AccessErratum to: Associations between DSM-IV mental disorders and diabetes mellitus: a role for impulse control disorders and depression
- Open Access
- 1 January 1997
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 7 (3) , 135-141
Cost-Effectiveness Analysis of Mass Screening for Cervical Cancer in Japan
Cost-effectiveness analysis for cervical cancer screening in Japan was performed to estimate the cost per life-year saved by the screening; cost-effectiveness ratio (CER). The analysis was made using a simulation model to estimate long-term cost and effectiveness of the screening programs. CER of cervical cancer screening was estimated to be US 40, 604 which was 2.4 times more expensive than that for gastric cancer screening but was about the same as that for colorectal cancer screening. It was within the range of cost-effectiveness of other cancer screening programs financed under the Health and Medical Services Law for the Aged in Japan. We performed sensitivity analysis on the following seven estimates, the screening charge, the sensitivity and the specificity of the screening test, the frequency of carcinoma in situ (CIS) among cases detected in the screening program, the initial cost and the terminal cost for patients with invasive cancer, and the incidence rate of cervical cancer. The sensitivity analysis demonstrated that the screening charge was the most influential factor on CER. CER was fairly stable under various assumptions on the accuracy of the screening test, the frequency of carcinoma in situ (CIS), the treatment cost for patient, and the incidence of cervical cancer. CER was less sensitive to the changes in incidence, even to as low as a 50% decrease of the current figure. Then if the incidence rate becomes 85% of the current figure in 2015, CER would be US 48, 176 and it was suggested that the cervical cancer screening would remain reasonably costeffective until the year 2015. J Epidemiol, 1997 ; 7 : 135-141.
- 1 January 1997
- Published by Japan Epidemiological Association in Journal of Epidemiology
- Vol. 7 (3) , 135-141
Open AccessCost-Effectiveness Analysis of Mass Screening for Cervical Cancer in Japan
Cost-effectiveness analysis for cervical cancer screening in Japan was performed to estimate the cost per life-year saved by the screening; cost-effectiveness ratio (CER). The analysis was made using a simulation model to estimate long-term cost and effectiveness of the screening programs. CER of cervical cancer screening was estimated to be US 40, 604 which was 2.4 times more expensive than that for gastric cancer screening but was about the same as that for colorectal cancer screening. It was within the range of cost-effectiveness of other cancer screening programs financed under the Health and Medical Services Law for the Aged in Japan. We performed sensitivity analysis on the following seven estimates, the screening charge, the sensitivity and the specificity of the screening test, the frequency of carcinoma in situ (CIS) among cases detected in the screening program, the initial cost and the terminal cost for patients with invasive cancer, and the incidence rate of cervical cancer. The sensitivity analysis demonstrated that the screening charge was the most influential factor on CER. CER was fairly stable under various assumptions on the accuracy of the screening test, the frequency of carcinoma in situ (CIS), the treatment cost for patient, and the incidence of cervical cancer. CER was less sensitive to the changes in incidence, even to as low as a 50% decrease of the current figure. Then if the incidence rate becomes 85% of the current figure in 2015, CER would be US 48, 176 and it was suggested that the cervical cancer screening would remain reasonably costeffective until the year 2015. J Epidemiol, 1997 ; 7 : 135-141.